Germany Neurostimulation Devices Market Size & Outlook
Germany neurostimulation devices market, 2018-2030 (US$M)
Related Markets
Germany neurostimulation devices market highlights
- The Germany neurostimulation devices market generated a revenue of USD 209.2 million in 2023 and is expected to reach USD 525.9 million by 2030.
- The Germany market is expected to grow at a CAGR of 14.1% from 2024 to 2030.
- In terms of segment, spinal cord stimulator was the largest revenue generating product in 2023.
- Sacral Nerve Stimulator is the most lucrative product segment registering the fastest growth during the forecast period.
Neurostimulation devices market data book summary
| Market revenue in 2023 | USD 209.2 million |
| Market revenue in 2030 | USD 525.9 million |
| Growth rate | 14.1% (CAGR from 2023 to 2030) |
| Largest segment | Spinal cord stimulator |
| Fastest growing segment | Sacral Nerve Stimulator |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Electric Stimulator |
| Key market players worldwide | Medtronic PLC, LivaNova PLC, Boston Scientific Corp, St. Jude Medical, Nevro Corp |
Other key industry trends
- In terms of revenue, Germany accounted for 3.3% of the global neurostimulation devices market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany neurostimulation devices market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 525.9 million by 2030.
Spinal cord stimulator was the largest segment with a revenue share of 50.81% in 2023. Horizon Databook has segmented the Germany neurostimulation devices market based on spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, gastric electric stimulator covering the revenue growth of each sub-segment from 2018 to 2030.
According to German Depression Foundation’s Depression Barometer 2018, around 5.3 million people in Germany between 18 and 79 years of age are diagnosed with depression every year. In addition, women are affected by depression three times more than the men.
As per OECD, in 2017, Germany spent 11.3% of GDP on healthcare. Thus, increasing prevalence of diseases such as depression, technological advancements, and rising healthcare expenditure are factors expected to drive the market.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Neurostimulation Devices Market Scope
Neurostimulation Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Germany neurostimulation devices market size, by product, 2018-2030 (US$M)
Germany Neurostimulation Devices Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
